Anti-obesity Drugs Market is expanding rapidly with Novo Nordisk announced the Phase IIIa obesity trial for an oral formulation
Weight loss drugs or anti-obesity drugs are pharmacological substances that regulate weight or reduce it. These drugs change one of the most fundamental processes of our body, weight regulation, through altering either absorption appetite or activity of calories in the body. One of the most obvious reasons for the high adoption of anti-obesity drugs is rising burden of obesity and relevant chronic diseases. As per the World Health Organization (WHO), in 2016, over 1.9 billion adults aged 18 years and above were overweight, of which around 650 million were obese. As per the same source, in 2016, around 340 million children and adolescents aged 5-19 years were overweight or obese. Such high incidence of obesity has necessitated the adoption of effective drugs. Hence, such factors can stimulate the growth of the anti-obesity drugs market. Lifestyle and eating habits across the globe have changed becoming increasingly unhealthy. Such unhealthy cousin habits are leading to the emerg...